EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney

Hyunjin Ryu, Eunjeong Kang, Seokwoo Park, Sehoon Park, Kyoungbun Lee, Kwon Wook Joo, Hajeong Lee

Kidney Research and Clinical Practice · 2015-12 · 34 (4) · 237-240

DOI: 10.1016/j.krcp.2015.06.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney Research and Clinical Practice, 2015-12. Verfasst von Hyunjin Ryu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thrombotic microangiopathy (TMA) is a rare complication of gemcitabine treatment. A 55-year-old man with a history of urothelial cancer underwent right ureteronephrectomy and palliative chemotherapy. The patient presented with dyspnea, generalized edema with foamy urine, and new-onset hypertension with acute kidney injury (AKI). Although AKI with oliguria was evident, thrombocytopenia and hemolytic anemia were not overt. To determine the cause of rapidly progressive azotemia, kidney biopsy was performed despite a single kidney and revealed chronic TMA. Microangiopathic hemolytic anemia and thrombocytopenia developed after renal biopsy. Diagnosed as gemcitabine-induced TMA, gemcitabine cessation and active treatment including steroids, plasmapheresis, and rituximab were carried out, but the patient׳s condition progressed to a dialysis-dependent state. Gemcitabine-induced TMA is often difficult to diagnose because of its variable clinical course. Therefore, heightened awareness of this potentially lethal complication of gemcitabine is essential; renal biopsy may be helpful.

Schlagwörter

Stichwörter der Autor:innen

GemcitabineThrombotic microangiopathyUrothelial carcinoma

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.

Zitieren

APA

Ryu, H., Kang, E., Park, S., Park, S., Lee, K., Joo, K. W., & Lee, H. (2015). A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney. Kidney Research and Clinical Practice, 34(4), 237-240. https://doi.org/10.1016/j.krcp.2015.06.001

Vancouver

Ryu H, Kang E, Park S, Park S, Lee K, Joo KW, et al. A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney. Kidney Research and Clinical Practice. 2015;34(4):237-240. doi:10.1016/j.krcp.2015.06.001

BibTeX
@article{Ryu2015,
  author = {Ryu, Hyunjin and Kang, Eunjeong and Park, Seokwoo and Park, Sehoon and Lee, Kyoungbun and Joo, Kwon Wook and Lee, Hajeong},
  title = {A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney},
  journal = {Kidney Research and Clinical Practice},
  year = {2015},
  volume = {34},
  number = {4},
  pages = {237--240},
  doi = {10.1016/j.krcp.2015.06.001}
}
Kostenlos starten →